Purpose: Tumor antigen–specific monoclonal antibodies (mAb) block oncogenic signaling
and induce Fcγ receptor (FcγR)–mediated cytotoxicity. However, the role of CD8 + CTL and …

The EGFR-targeted antibody cetuximab is effective against head and neck cancer (HNSCC),
but in only 15% to 20% of patients, and the variability and extent of cetuximab-mediated …

Tumor antigen (TA)-targeted monoclonal antibodies (mAb), trastuzumab, cetuximab,
panitumumab, and rituximab, have been among the most successful new therapies in the present …

Immunotherapy with the EGFR-specific mAb cetuximab is clinically effective in 10–20% of
patients with squamous cell carcinoma of the head and neck (SCCHN). Little information is …

Thyroid carcinoma consists a group of phenotypically heterogeneous cancers. Recent advances
in biological technologies have been advancing the delineation of genetic, epigenetic, …

Using morphological criteria, death pathways in outer hair cells (OHCs) were determined in
chinchilla organs of Corti that had been exposed to a high- or moderate-level octave band of …

… This series was limited to patients with Kadish A and B disease with the author's current
preference for open craniofacial resection for Kadish C diease. Another report on 18 patients …

Objective To evaluate the clinical applications and limitations of chat generative pretrained
transformer (ChatGPT) in otolaryngology. Study Design Cross‐sectional survey. Setting …

Tumor recurrence following treatment remains a major clinical challenge in oral cavity
cancer. Cancer stem cells (CSCs) have been isolated from human oral cancers and been …

We sought to identify biomarkers of antitumor activity in patients with locally advanced head
and neck cancer treated with therapy containing cetuximab, an epidermal growth factor …